Monopar Therapeutics Inc

NASDAQ:MNPR   12:43:28 PM EDT
4.85
-0.13 (-2.61%)
Other Pre-Announcement

Monopar Therapeutics Reports Q3 Loss Per Share $0.15

Published: 11/12/2020 14:32 GMT
(MNPR) - Monopar Therapeutics Reports Third Quarter 2020 Financial Results and Business Update.
Q3 Loss per Share $0.15.
Q3 Earnings per Share Estimate $-0.15 -- Refinitiv Ibes Data (analyst estimates).
Anticipates That Its Current Cash and Cash Equivalents Will Fund Company's Planned Operations Through 2021.
Cash and Cash Equivalents As of September 30, 2020 Were $18.0 Million.